This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Artios Pharma Ltd.
Description: The Pol-Theta Program targets the pol-theta molecule which is thought to control DNA repair processes in certain tumours. Knocking out the target could remove a path relied on by the cancer cell, causing it to die.
Pol-Theta Program News
Additional information available to subscribers only: